Market Overview - On October 22, the medical device sector declined by 0.71%, with Kewei Medical leading the drop [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Top Performers - Shengxiang Biological (688289) saw a closing price of 22.02, with an increase of 8.31% and a trading volume of 254,100 shares, totaling 550 million yuan [1] - Meihua Medical (301363) closed at 23.83, up 6.53%, with a trading volume of 128,000 shares, amounting to 300 million yuan [1] - Lideman (300289) closed at 8.19, increasing by 6.36%, with a trading volume of 529,400 shares, totaling 433 million yuan [1] Underperformers - Kewei Medical (301087) closed at 40.63, down 4.78%, with a trading volume of 27,100 shares, totaling 112 million yuan [2] - Lepu Medical (300003) closed at 17.35, down 4.41%, with a trading volume of 330,000 shares, totaling 580 million yuan [2] - Ruimaite (301367) closed at 87.18, down 3.48%, with a trading volume of 15,100 shares, totaling 133 million yuan [2] Capital Flow - The medical device sector experienced a net outflow of 332 million yuan from institutional investors, while retail investors saw a net inflow of 261 million yuan [2][3] - The top net inflows from retail investors included Lideman (300289) with a net outflow of 80.35 million yuan, and Shengxiang Biological (688289) with a net outflow of 17.66 million yuan [3]
医疗器械板块10月22日跌0.71%，可孚医疗领跌，主力资金净流出3.32亿元